TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2023
Voltar para busca
Dado oficial do USPTO
ARC INNOVATION AT SHEBA MEDICAL CENTER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
15/07/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 42
Data de depósito
16/02/2021
Data de registro
04/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2022
Última transação
15/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
IL
Examinador
JOINER, KATINA
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of he letters ARC in a large, blue stylized font with a yellow dot in the center of the letter C. Beneath ARC is the stylized wording INNOVATION AT SHEBA MEDICAL CENTER in black.
Titulares e representantes
Titulares
The Sheba Fund for Health Services and Research (R.A)
Representantes
JACQUELINE ZION PEARL COHEN ZEDEK LATZER BARATZ LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Consultancy relating to the commercialization of medical products and technologies; business management of all types (commercialoperationdevelopment and marketing) of development centers and business incubators in the fields of medical products and technologies; commercialization of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposesveterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticalsanti-cancer preparationsbiological preparationsvaccine preparations
Classe 42
Consultancy relating to the development of medical products and technologies; design and development of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposesveterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticalsanti-cancer preparationsbiological preparationsvaccine preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/03/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
26/01/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
26/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
25/08/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
24/08/2022
APET
ASSIGNED TO PETITION STAFF
22/08/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/08/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
10/05/2022
APET
ASSIGNED TO PETITION STAFF
10/05/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
18/04/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
14/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/02/2022
PUBO
PUBLISHED FOR OPPOSITION
15/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/01/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/01/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/01/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/01/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2021
RFNT
REFUSAL PROCESSED BY IB
25/10/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2021
RFRR
REFUSAL PROCESSED BY MPU
27/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/09/2021
CNRT
NON-FINAL ACTION WRITTEN
11/09/2021
DOCK
ASSIGNED TO EXAMINER
11/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
27/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ARC INNOVATION AT SHEBA MEDICAL CENTER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.